Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
IDWeek 2025: Zoster Vaccine Linked to Lower Cardiovascular, Dementia Risk
October 2025
Prior zoster vaccination reduces risks of cardiovascular events, dementia, and death after shingles infection, new IDWeek 2025 data show.
Read more
18 Oct 2025
EACS 2025: Doxy-PEP Cuts Chlamydia and Syphilis Risk in Men Living With HIV
EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.
17 Oct 2025
EACS 2025: Over Half of HIV Diagnoses in Migrants Occur Years Post-Migration
EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.
16 Oct 2025
EACS 2025: Low Risk of HBV Reactivation After Tenofovir Withdrawal in People With HIV
EACS 2025 study shows minimal HBV reactivation after stopping tenofovir in people with HIV, supporting safe use of tenofovir-sparing ART.
16 Oct 2025
EACS 2025: Once-Weekly HIV Pill Maintains Viral Suppression for 96 Weeks
New EACS data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance or major side effects.
12
Mins
27 May 2025
Review of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2025
THIS SPRING, Vienna, Austria played host to a momentous gathering, welcoming over 15,000 attendees from across five continents for the 35th ESCMID Global Congress..
3
Mins
27 May 2025
New Frontiers in Antimicrobial Stewardship
AT the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2025, Karin Thursky, Director of the National Centre for Antimicrobial Stewardship…
5
Mins
27 May 2025
Tackling Tuberculosis: The Current Landscape and Future Directions
The presentation by Guy Thwaites, Director of the Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam, focused on the current state of tuberculosis…
7
Mins
14 May 2025
ESCMID Global 2025 Interview: F-Xavier Lescure
The quality of the response depends on the quality of the preparedness phase, particularly today, when we are living in a chronic and…
Loading posts...
1
2
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View